Recent trends in hepatitis B virus infection in the general Korean population

被引:54
作者
Kim, Hyuck
Shin, A. Ri
Chung, Hoe Hoon
Kim, Min Kyoung
Lee, Ji Sung
Shim, Jae-Jun
Kim, Byung-Ho
机构
[1] Department of Internal Medicine, Kyung Hee University Medical Center, Seoul
[2] Department of Biostatistics, Korea University College of Medicine, Seoul
关键词
VACCINATION;
D O I
10.3904/kjim.2013.28.4.413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Hepatitis B virus (HBV) is the major cause of chronic liver disease in Korea, but viral prevalence has decreased because of hepatitis B vaccination programs. In this study, we investigated longitudinal changes in HBV in fection in the general Korean population. Methods: HBV surface antigen (hepatitis B surface antigen, HBsAg) seropositivity was assessed from the Korea National Health and Nutrition Examination Survey (I to V). In total, 50,140 subjects were tested for serum HBsAg positivity over a period of 12 years (1998 to 2010). Results: The prevalence of HBsAg seropositivity decreased over the study period. The rates of HBsAg carriers were 4.61% in 1998, 4.60% in 2001, 3.69% in 2005, 3.01% in 2008, and 2.98% in 2010 (p < 0.0001). The reduction in HBV infection rates was more prominent in younger age groups. Among teenagers (10 to 19 years), the percentage of HBsAg carriers decreased from 2.2% in 1998 to 0.12% in 2010 (p < 0.0001). Among those aged io to 39 years, the percentage of HBV infection decreased from 4.72% in 1998 to 2.29% in 2010 (p < 0.0001). However, no decreasing trend in HBsAg positivity was observed among those aged 50 or older (p > 0.05). Neither gender nor socioeconomic status were associated with the decreased prevalence of HBsAg carriers. Conclusions: HBV infection has decreased in the Korean population since the advent of vaccination programs. However, the decrease is limited to the younger population, and viral persistence remains in the middle-aged and older population.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 21 条
  • [11] Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009
    Jung, Kyu-Won
    Park, Sohee
    Kong, Hyun-Joo
    Won, Young-Joo
    Lee, Joo Young
    Seo, Hong Gwan
    Lee, Jin-Soo
    [J]. CANCER RESEARCH AND TREATMENT, 2012, 44 (01): : 11 - 24
  • [12] Korea Centers for Disease Control and Prevention, 2010, 5 KOR NAT HLTH NUTR
  • [13] Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: Sixteen years after newborn vaccination program in Taiwan
    Lin, HH
    Wang, LY
    Hu, CT
    Huang, SC
    Huang, LC
    Lin, SSJ
    Chiang, YM
    Liu, TT
    Chen, CL
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (04) : 471 - 474
  • [14] HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant
    Louisirirotchanakul, S
    Kanoksinsombat, C
    O'Charoen, R
    Fongsatikul, L
    Puapairoj, C
    Lulitanond, V
    Appassakij, H
    Promwong, C
    Wasi, C
    [J]. VIRAL IMMUNOLOGY, 2006, 19 (01) : 108 - 114
  • [15] Comparison of the Technical and Clinical Performance of the Elecsys® HBsAg II Assay With the Architect®, AxSym®, and Advia® Centaur HBsAg Screening Assays
    Louisirirotchanakul, S.
    Khupulsup, K.
    Akraekthalin, S.
    Chan, K. P.
    Saw, S.
    Aw, T. C.
    Cho, D-H.
    Shin, M-G.
    Lim, J.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (05) : 755 - 762
  • [16] Manetta T, 2001, Minerva Med, V92, P393
  • [17] Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1
  • [18] HEPATITIS-B - GLOBAL IMPORTANCE AND NEED FOR CONTROL
    MAYNARD, JE
    [J]. VACCINE, 1990, 8 : S18 - S20
  • [19] Impacts of Vaccination on Hepatitis B Viral Infections in Korea over a 25-Year Period
    Park, Neung Hwa
    Chung, Young-Hwa
    Lee, Hyo-Suk
    [J]. INTERVIROLOGY, 2010, 53 (01) : 20 - 28
  • [20] Infant and adolescent hepatitis B immunization up to 1999: a global overview
    Vryheid, RE
    Kane, MA
    Muller, N
    Schatz, GC
    Bezabeh, S
    [J]. VACCINE, 2000, 19 (9-10) : 1026 - 1037